SCHEMBL19650679

SCHEMBL19650679

CNCCc1cn(C)c2ccc(F)c(OCc3ccccc3)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.40
ATM Q13315 1/20 0.38
KDM1A O60341 5/20 0.38
BCHE P06276 4/20 0.37
SNCA P37840 1/20 0.35
TMEM97 Q5BJF2 1/20 0.34
CARM1 Q86X55 1/20 0.34
PRMT6 Q96LA8 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
PRMT8 Q9NR22 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
SLC6A4 P31645 2/20 0.34
ALDH1A1 P00352 1/20 0.34
PKM P14618 1/20 0.34
HTR2C P28335 1/20 0.34
HTR1A P08908 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1163043 0.91 TAAR1 (0.39) TAAR1ATMSNCASIGMAR1
SCHEMBL1163145 0.91 TAAR1 (0.42) TAAR1SNCACARM1PRMT6MAOB
SCHEMBL1163258 0.90 TAAR1 (0.41) TAAR1SNCACARM1PRMT6MAOA
SCHEMBL1163355 0.90 CARM1 (0.35) TAAR1SNCACARM1PRMT6SLC6A4
SCHEMBL1163327 0.88 TAAR1 (0.50) TAAR1CARM1PRMT6MAOBSLC6A4
SCHEMBL1162963 0.88 TAAR1 (0.46) TAAR1SNCACARM1PRMT6MAOA
SCHEMBL12558410 0.87 HTR2A (0.46) KDM1AMAOAMAOBSLC6A4HTR2C
SCHEMBL12558406 0.87 KDM1A (0.40) KDM1ABCHEMAOAMAOBSLC6A4
SCHEMBL1162971 0.86 HTR1B (0.43) TAAR1CARM1PRMT6HRH3ALDH1A1
SCHEMBL1163179 0.86 CARM1 (0.41) TAAR1CARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170342054-A1 COMPOUNDS AND METHODS OF USE THEREOF ELDER AMY (US) 2017-11-30 US disclosed
US-20170342054-A1 COMPOUNDS AND METHODS OF USE THEREOF ELDER AMY (US) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342054-A1 COMPOUNDS AND METHODS OF USE THEREOF AANAT, HNMT, INMT TAAR1 1521/4885ATM 2349/4885KDM1A 3195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.